Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer
Sumiya Dalangood, Zhen Zhu, Zhihui Ma, Jiaxuan Li, Qinghe Zeng, Yi‐Lin Yan, Bing Shen, Jun Yan, Ruimin Huang
Abstract
Herein, we successfully identified a novel 14-gene signature for glycogene-type classification of UBC patients. ST3GAL6 gene, from this signature, was demonstrated as a potential biomarker for poor outcomes and cell invasion in UBCs.
Topics & Concepts
Bladder cancerBiomarkerCancerUrinary systemUrinary Bladder CancerMedicineIdentification (biology)OncologyInternal medicineBiologyPathologyCancer researchEcologyBiochemistryBladder and Urothelial Cancer TreatmentsRNA modifications and cancerEsophageal Cancer Research and Treatment